Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and
transdiagnostic clinical approach to working with patients who are using or considering …

Andrew Penn is an associate clinical professor in the University of California, San Francisco
School of Nursing. Caroline G. Dorsen is an associate professor and associate dean for …

There is a growing body of research suggesting that palliative care patients coping with
existential distress may benefit from psilocybin. However, there is a large gap regarding the …

Background and Objectives The popularity of tryptamines such as N, N‐dimethyltryptamine
(DMT) appears to be increasing in the United States (US), but epidemiologic literature on …

The research and use of psychedelic medicines to treat common mental health disorders
has increased substantially in the past 2 decades. At the same time, knowledge is relatively …

In recent years, researchers in the “psychedelic renaissance” have been reinvestigating the
therapeutic potential of psychedelic compounds for conditions like post-traumatic stress …

The field of psychedelic research is undergoing a revival, yet research focused on non-
clinical psychedelic use remains relatively limited. The current qualitative study sheds light …

In the past decade, the consumption of psilocybin mushrooms has become a popular
therapeutic tool for people looking to deal with mental and emotional health issues. The …

The use of psychedelic substances is increasingly associated with nature-relatedness. We
explore whether entheogenic uses of ayahuasca in settings co-produced between …

San Pedro, a mescaline containing cactus, has been used for thousands of years and is
currently popular as a psychedelic substance in ceremonial retreats in Europe. The current …